Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2025-04-30' to '2025-05-13'.SummaryDifference1%
- Check34 days agoChange DetectedThe web page has been updated to reflect a new version, v2.15.2, and the previous version, v2.15.0, has been removed. Additionally, a date of April 30, 2025, has been added.SummaryDifference1.0%
- Check48 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check56 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.6%
- Check85 days agoChange DetectedThe date has been updated from January 27, 2025, to March 7, 2025.SummaryDifference0.6%
Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.